For someone trying to avoid an ongoing weight-loss subscription, Contour Health makes a straightforward promise: pay for medication by the vial when you decide to reorder, with consultations and follow-up included. The contractual question is not simply whether that sounds flexible. It is what happens between the free consultation, the payment and the pharmacy order—and which obligations survive a decision not to buy another vial. The public pages describe a relatively clear reorder process, but their price and supply descriptions do not always agree.
This review examines Contour Health’s public documentation consulted October 19, 2026, with particular attention to commitments, cancellation and service responsibilities. Contour presents itself as a clinician-led telehealth service offering compounded injectable semaglutide and tirzepatide, with Strive Pharmacy preparing and filling prescriptions. Its weight-loss offering should not be confused with its automatically renewing hair-loss program. Nor should the advertised weekly or monthly price be mistaken for the amount charged at checkout: the documented purchasing unit for weight treatment is a vial, with the final price confirmed individually.
At a glance
- Weight-loss payment model
- Contour advertises payment by the vial when patients choose to reorder, without a subscription, membership or automatic refill.Sources: [5]
- Starting-price discrepancy
- The weight page lists compounded semaglutide from $30 per week in its comparison table but from $25 per week in its calculator; compounded tirzepatide starts at $50 per week.Sources: [6]
- Refund boundary
- The general terms state that all products purchased through Contour Health are non-refundable.Sources: [3]
- Pharmacy responsibility
- Contour says it does not manufacture medication; prescriptions are compounded and filled by Strive Pharmacy, described as a U.S. 503A compounding pharmacy.Sources: [5]
- Different rules for hair treatment
- The hair-loss program has quarterly automatic refills, an initial three-month commitment and cancellation by email at least 30 days before the next quarterly charge.Sources: [4]
Start with the program, not the general subscription clause
Contour’s homepage explicitly separates weight treatment from a recurring membership. Its wording says patients pay for medication by the vial when they decide to reorder, with “No subscription, no membership, no automatic refill.” The FAQs reinforce that weight loss, longevity and performance are billed per order when the patient and clinician decide to reorder. On that documentation, the weight-loss program is not presented as a monthly subscription requiring a cancellation request to prevent the next routine charge.
The general terms nevertheless describe subscriptions for certain products or services: a minimum of three consecutive months, automatic charges according to the relevant billing terms, and at least 30 days’ cancellation notice after the initial commitment. Those provisions should not automatically be assigned to weight treatment when its program-specific pages say otherwise. Equally, readers should not assume every Contour service follows the weight-loss arrangement. Our guide to enrollment terms worth reading closely explains why the actual program selection matters.
The clearest contrasting example is hair treatment. Contour lists a daily tablet at $148 every three months, presented as $49 per month, or a topical at $189 quarterly, presented as $63 per month. Each charge triggers a fresh three-month supply. The first supply is the minimum commitment; afterward, cancellation requires emailing reception@contourhealthrx.com at least 30 days before the next quarterly charge. The stated absence of a cancellation fee does not turn that program into pay-as-you-go weight care.
| Program or transaction | Documented payment structure | Boundary to confirm |
|---|---|---|
| Weight treatment | Pay by vial when deciding to reorder; no automatic refill advertised | Exact vial price and expected duration |
| Longevity and performance | Billed per order when patient and clinician decide to reorder | Product-specific quantity and total charge |
| Hair-loss tablet | $148 every three months; advertised as $49/month | Initial three-month commitment and 30-day cancellation notice |
| Hair-loss topical | $189 every three months; advertised as $63/month | Initial three-month commitment and 30-day cancellation notice |
| Purchased products | General terms say products are non-refundable | Handling of errors, damage and shipping problems |
The first payment needs a vial-level quote
Contour publishes prices rather than withholding every figure until consultation, but its semaglutide starting prices conflict. The homepage advertises weight treatment from $120 per month at the starting dose and says dose determines price. The weight-page table lists compounded injectable semaglutide from $30 per week and compounded injectable tirzepatide from $50 per week. A calculator on that same page instead shows semaglutide from $25 per week. These are starting figures, not a universal total for an order.
Supply descriptions also vary. A table footnote says medication is sold in two-month vials, while another passage says a vial typically lasts six to 14 weeks depending on dose. Neither description establishes a required treatment commitment, and the weekly figures should not be converted into an assumed calendar-month bill. The documentation does not resolve which semaglutide starting price would apply to a particular patient or provide a universal vial price that reconciles these statements.
Contour says the exact dose and cost are confirmed at the free consultation before any payment. That is the practical point at which to request the product, injectable presentation, vial volume, expected duration and total charge together. A written GLP-1 quote is more useful here than choosing the lowest advertised weekly figure. The next vial should also be treated as a new purchasing decision: the public pages do not establish a price lock for later orders or disclose a complete dose-by-dose price schedule.
Stopping future orders is different from reversing a purchase
The weight-loss reorder process is described as a conversation, not an automatic transaction. Patients contact their clinician, review progress and agree on the appropriate next vial size for the care plan. Once that is decided, payment is processed and the refill is ordered. This creates a useful distinction between discussing another prescription and authorizing another purchase. Before paying, ask how the clinic records that authorization and whether there is any opportunity to withdraw an order before pharmacy processing begins.
The general terms state that all products purchased through Contour are non-refundable. The consulted documentation does not detail exceptions for an incorrect order, damaged medication or a transportation problem. That makes the payment-to-order boundary more consequential than the absence of a subscription alone suggests. Being free not to order another vial is not the same as being entitled to recover money for a vial already purchased, and the pages do not document a general satisfaction guarantee.
For weight treatment, the published no-auto-refill promise reduces the need to track a recurring cancellation deadline. It does not answer how an already paid order can be stopped, changed or investigated. Ask for the clinic’s written process for those situations before authorizing the purchase, particularly if timing or travel could interfere with receipt. Our explanation of refund boundaries and exclusions provides a framework for separating cancellation of future charges from remedies for a specific purchase.
What the medication price includes—and where responsibility shifts
The homepage says patients pay only for medication, with the consultation, clinician time, individualized dosing, check-ins and shipping included. That is a meaningful description of the advertised partner-pharmacy arrangement, not a promise of free treatment. There is also a documentation tension: the FAQs advertise no shipping fees, while the general terms allow shipping and handling charges disclosed at purchase, plus applicable taxes. The consulted pages do not explain when those broader provisions would apply, so the final order should show any additional charge explicitly.
Insurance is another firm boundary. Contour’s terms say it does not participate in Medicare, Medicaid or private health insurance plans and that patients are financially responsible for products and services. It accepts credit or debit cards associated with HSA and FSA accounts, but does not guarantee that an administrator will approve the purchase as an eligible expense. Contour offers an itemized receipt, and a clinician may provide a letter of medical necessity on request; neither document guarantees reimbursement.
The partner-pharmacy arrangement also has an exception. If a prescription is unavailable through those pharmacies, the terms say Contour will send it to a pharmacy selected by the patient. The patient then assumes medication cost and responsibility for pickup or delivery. That provision should not be read as an unrestricted promise to transfer every prescription on identical financial terms. Ask whether the quoted package still applies if the pharmacy channel changes, and what services remain included if medication is purchased elsewhere.
Enrollment is an evaluation, not a prescription guarantee
The first appointment is a Zoom video consultation in which a licensed clinician reviews health history, discusses goals and decides whether a prescription is appropriate. Patients need internet access, a camera, a microphone and the Zoom app on a smartphone, tablet or computer. The terms require review and signature of an informed-consent agreement before telehealth services. Together, those steps describe an actual clinical intake process rather than a purchase that automatically entitles the buyer to medication.
Contour says no particular BMI is required to start the process and that no laboratory work is required before starting treatment. These are descriptions of its intake policy, not an assurance that every applicant qualifies or that testing could never become relevant to individual care. Its FAQs also say GLP-1s are generally not recommended for people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or those who are pregnant or breastfeeding; the clinician reviews the patient’s full history before prescribing. Its stated approach is an individualized assessment of medical necessity and appropriateness. Adults preparing for consultation should therefore distinguish permission to book from a clinician’s later decision about whether, and what, to prescribe.
Two access limits deserve attention. Contour claims availability in 46 states, excluding Michigan, Mississippi, Kentucky and Arkansas; those licensing and availability claims were not independently verified here. Its FAQs also advertise access from age 15, with parental consent and oversight for minors, while its terms restrict services to people who have reached the legal age of majority where they live. That inconsistency remains unresolved. The consulted documentation also does not establish Spanish-language appointments, interpretation or translated consent materials.
Who is responsible after the consultation?
The terms identify Desert Contour LLC, doing business as Contour Health, as the website’s owner and operator. They also say Contour is not a pharmacy or prescription fulfillment warehouse, but a facilitator connecting patients with pharmacies that dispense and deliver medication. The weight page names Melissa Musso, NP, as clinical lead and Dr. Laarni Gonzales-Naval as medical director, with board-certified nurse practitioners handling check-ins and dosing decisions. These are the provider’s descriptions, not independently verified credential findings.
Contour promises to match patients with a clinician licensed in their state and retain that same clinician throughout care. Its minimum follow-up schedule is a text check-in every two weeks, with patients welcome to contact the clinician more often or request video follow-up. Those are useful service commitments because included follow-up can otherwise be an undefined phrase. The pages do not establish a guaranteed appointment time for requested video visits or a continuous, around-the-clock clinical response service.
The stated typical clinician response time is about 24 hours, Monday through Friday; clinicians take weekends off. For direct clinician contact, the FAQs publish a text line at (435) 705-5696. Technical or logistical issues go to office staff by call or text at (435) 414-0360. Keeping those channels separate can help distinguish a treatment question from a delayed order or account issue. Our guide to platform, clinician and pharmacy responsibilities explains why a single brand does not mean a single service role.
The pharmacy order brings separate delivery questions
Contour identifies Strive Pharmacy as the organization compounding and filling prescriptions, describing it as a U.S. 503A compounding pharmacy licensed and inspected by its state pharmacy board. The site also makes accreditation and certification claims about its pharmacy partner, including NABP, PCAB and LegitScript references. Those statements are not independently verified in this review. Contour says it does not manufacture medication and that injectables are prepared under United States Pharmacopeia sterile-compounding standards and shipped with needed supplies.
The FAQ delivery estimate is more specific than a generic shipping promise: medication typically arrives at the patient’s home three to five business days after it is prescribed. That is an advertised arrival estimate, not merely a dispatch window, but it does not separately define clinical review, pharmacy preparation or shipment timing. The terms additionally warn that partner-pharmacy prescriptions may not come in child-resistant containers. Patients should ask who handles tracking problems and what packaging and storage information will accompany the particular order.
Delivery quality has a clinical boundary as well as a customer-service one. FDA advises not using an injectable GLP-1 drug that arrives warm or inadequately refrigerated and contacting the provider or dispensing pharmacy to resolve the concern. That advice does not itself establish Contour’s refund or replacement policy. Because its public terms do not spell out shipping-incident exceptions to non-refundability, obtain the handling process before ordering rather than assuming that included shipping also specifies a remedy for every delivery problem.
Clear terms do not establish clinical outcomes
Contour acknowledges that compounded medications are not FDA approved and that FDA does not review them for safety or effectiveness. Its weight page also says the trial results it presents concern FDA-approved branded medications. That distinction matters: trial results for those products do not establish outcomes for Contour’s compounded preparations or predict an individual patient’s response. FDA approval applies to a particular product, not to Contour as a clinic or to a pharmacy as an institution.
FDA recommends compounded drugs when an individual’s medical needs cannot be met by an FDA-approved drug, with a prescription and a state-licensed pharmacy. Nonapproval alone does not prove clinical inequivalence, but a convenient payment arrangement cannot fill the evidence gap either. FDA has also received reports of compounded-medication measurement and administration errors, including some associated with hospitalization. Instructions therefore need to come from the prescriber or pharmacist; the website’s weekly price and vial-duration descriptions are not medication-use instructions.
Contour’s broader catalog includes NAD+, sermorelin, and hair treatments involving finasteride and minoxidil, alongside its compounded GLP-1 offering. It also provides educational material that it labels general information rather than a substitute for medical advice. These additional offerings help explain why its general terms cover more than one payment model. They do not establish that a weight-treatment customer must purchase other services, or that commercial claims about one program substantiate another program’s clinical benefits.
Questions & answers
Does Contour Health require a three-month weight-loss subscription?
Its weight-loss pages say no subscription, membership or automatic refill, with payment by vial when the patient decides to reorder. The three-month subscription language appears in general terms for certain services, and the hair-loss program specifically has an initial three-month commitment. Confirm that your enrollment and payment authorization identify weight treatment as the advertised per-order arrangement.
Is semaglutide $25 or $30 per week?
Both starting figures appear on the consulted weight page: $30 per week in the table and $25 in the calculator. The page says dose affects price and the exact cost is confirmed at the free consultation before payment. Neither figure establishes a total vial charge. Request the applicable starting price and complete order amount together.
Can I get a refund if I stop treatment?
The general terms say purchased products are non-refundable. The weight-loss promise allows patients not to initiate another order, but it does not promise reimbursement for a previous purchase. The consulted pages do not detail exceptions for damage, order errors or transportation incidents. Ask how those situations are handled before payment, especially if the medication has already been ordered from the pharmacy.
Are follow-up appointments and shipping included?
The homepage includes consultation, clinician time, individualized dosing, check-ins and shipping in the medication price. The FAQs describe text follow-up at least every two weeks and the option to request video follow-up. However, the general terms allow disclosed shipping and handling charges and applicable taxes. Confirm the final order’s total rather than treating the broad inclusion statement as resolving every possible charge.
Can I use insurance or an HSA/FSA card?
Contour says it does not participate in Medicare, Medicaid or private insurance plans. It accepts HSA/FSA-linked payment cards, but administrator approval is not guaranteed. It offers itemized receipts, and a clinician may provide a letter of medical necessity on request. Those payment and documentation options do not establish insurance coverage or guarantee that an account administrator will reimburse the expense.
How quickly can I receive medication and reach my clinician?
Contour advertises typical home arrival three to five business days after prescribing, without separate timelines for evaluation and pharmacy preparation. Clinicians typically respond in about 24 hours on weekdays, not throughout weekends. The published clinician text line is (435) 705-5696; office staff handle technical and logistical issues at (435) 414-0360. Neither estimate should be read as guaranteed immediate access.
Our assessment
Contour Health documents a weight-loss purchasing model with a meaningful distinction from subscription care: patients decide whether to order another vial, while consultation and ongoing check-ins are advertised as included. It also identifies the pharmacy, describes clinical contact channels and explains how a refill becomes a paid order. The weaknesses are concentrated where a purchaser needs precision: conflicting semaglutide starting prices, inconsistent vial-duration descriptions, general terms that differ from program-specific promises, and limited detail about remedies for a problematic purchase. Before paying, obtain a written vial-level quote, confirmation that no recurring weight-loss charge is authorized, and the process for order changes and delivery concerns. Those answers would clarify the transaction; they would not independently verify licensing claims or establish the effectiveness of the compounded medication.
This opens the reviewed business’s website. The link is not a prescription or endorsement. Commercial relationships.
Sources & documentation
Public materials consulted October 19, 2026. Provider statements are attributed claims, not independently verified clinical outcomes. Terms can change; obtain a current written quote.